Hub : Traits :

Medication: Paracetamol

416 significantly associated models · 38 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 173885712 175194390 1 1 1.3e-07 2.6e-09 1.0e+00 100 RABGAP1L
2 1 242590540 244359621 3 1 6.7e-11 8.2e-11 3.3e-01 98 SDCCAG8
3 3 48618666 50448632 6 1 7.0e-08 2.5e-06 3.4e-01 96 RNF123
4 6 12020241 13990267 2 1 3.3e-08 1.8e-08 1.0e+00 100 RP1-257A7.5
5 6 25285943 26689223 1 1 1.3e-11 2.8e-13 8.8e-05 71 U91328.21
6 6 96275538 97699026 2 1 9.8e-09 8.4e-10 2.4e-02 86 KIAA0776
7 8 140969818 142706843 1 1 4.8e-08 1.3e-04 8.4e-01 100 PTK2
8 9 125444045 127385609 1 1 1.5e-07 7.8e-07 7.0e-01 99 DENND1A
9 12 56805309 58303535 2 1 1.2e-18 2.1e-18 1.0e+00 100 LRP1
10 17 42774693 45796313 19 1 4.3e-15 7.4e-15 1.0e+00 100 LRRC37A4P

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 3.42 2 1 2.2 0.00 1.0e+00 SDCCAG8 U91328.21
Depressed Affect (Nagel 2018) 9.41 4 2 4.4 0.99 9.9e-03 LRRC37A4P PTK2 RNF123 SDCCAG8
Depression (Nagel 2018) 3.60 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Intelligence (Savage-Jansen 2018) 5.21 4 2 4.4 -0.95 5.5e-02 LRRC37A4P PTK2 RABGAP1L RNF123
Neuroticism (Nagel 2018) 7.88 2 1 2.2 0.00 1.0e+00 LRRC37A4P RABGAP1L
Schizophrenia (2018) 4.49 2 1 2.2 0.00 1.0e+00 SDCCAG8 U91328.21
Worry (Nagel 2018) 4.39 2 1 2.2 0.00 1.0e+00 LRRC37A4P RABGAP1L
Irritable Bowel Disease (IBD) 1.91 1 1 2.2 0.00 1.0e+00 RNF123
Ulcerative Colitis (UC) 2.41 1 1 2.2 0.00 1.0e+00 RNF123
Major Depression (MDD) 2.62 1 0 0.0 0.00 1.0e+00 RNF123
Verbal and Numeric Reasoning (VNR) 4.76 3 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123 U91328.21
Breast Cancer 3.68 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Ovarian Cancer 5.40 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Prostate Cancer 3.05 1 0 0.0 0.00 1.0e+00 RNF123
Age at First Birth 4.53 1 1 2.2 0.00 1.0e+00 RNF123
Coronary Artery Disease (CAD) 5.15 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Neuroticism (2016) 4.96 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Primary Biliary Cirrhosis 3.47 2 0 0.0 0.00 1.0e+00 LRP1 LRRC37A4P
Schizophrenia (2014) 2.49 1 0 0.0 0.00 1.0e+00 SDCCAG8
Ulcerative Colitis 2.31 1 0 0.0 0.00 1.0e+00 RNF123
Blood Eosinophil Count 2.66 2 2 4.4 0.00 1.0e+00 LRP1 LRRC37A4P
Blood Platelet Count 0.63 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Blood Red Count 6.38 3 2 4.4 0.00 1.0e+00 LRRC37A4P RABGAP1L RP1-257A7.5
Blood White Count 1.63 3 1 2.2 0.00 1.0e+00 LRRC37A4P PTK2 RNF123
Heel T-Score 2.26 3 1 2.2 0.00 1.0e+00 DENND1A LRRC37A4P RNF123
BMI 2.84 4 1 2.2 -0.41 5.9e-01 DENND1A LRP1 RABGAP1L RNF123
Height 0.92 2 2 4.4 0.00 1.0e+00 LRP1 LRRC37A4P
Waist Hip Ratio (WHR) 3.69 3 1 2.2 0.00 1.0e+00 LRRC37A4P PTK2 RNF123
Systolic Blood Pressure 3.21 4 3 6.7 -0.76 2.4e-01 KIAA0776 LRRC37A4P RP1-257A7.5 SDCCAG8
Smoking Status 3.64 2 1 2.2 0.00 1.0e+00 PTK2 RNF123
Allergy or Eczema 1.96 1 0 0.0 0.00 1.0e+00 LRP1
Cardiovascular Disease 1.71 1 0 0.0 0.00 1.0e+00 SDCCAG8
Hypothyroidism (self reported) 1.76 1 0 0.0 0.00 1.0e+00 PTK2
Respiratory disease 3.45 2 1 2.2 0.00 1.0e+00 LRP1 RABGAP1L
Lung FEV1/FVC ratio 4.47 3 2 4.4 0.00 1.0e+00 LRP1 LRRC37A4P RNF123
Lung FVC 6.25 2 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123
Neuroticism 8.55 3 1 2.2 0.00 1.0e+00 LRRC37A4P RABGAP1L RNF123
Chronotype (morning person) 2.34 2 0 0.0 0.00 1.0e+00 DENND1A RNF123
Hair Pigment 0.31 3 1 2.2 0.00 1.0e+00 DENND1A LRP1 LRRC37A4P
Hand grip strength (left) 3.02 2 2 4.4 0.00 1.0e+00 LRRC37A4P RP1-257A7.5
Number of treatments/medications taken 7.38 4 0 0.0 0.97 2.6e-02 LRP1 RABGAP1L RNF123 SDCCAG8
Sensitivity / hurt feelings 7.16 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Frequency of depressed mood in last 2 weeks 3.89 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Hearing difficulty/problems: Yes 2.93 1 1 2.2 0.00 1.0e+00 PTK2
Relative age of first facial hair 7.60 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Systolic blood pressure, automated reading 3.50 3 1 2.2 0.00 1.0e+00 KIAA0776 LRRC37A4P RP1-257A7.5
Angina 2.94 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Vitamin and mineral supplements 4.76 1 1 2.2 0.00 1.0e+00 LRP1
Impedance of leg (right) 2.07 3 2 4.4 0.00 1.0e+00 LRRC37A4P PTK2 RNF123
Leg fat-free mass (left) 1.31 1 0 0.0 0.00 1.0e+00 RNF123
Trunk fat percentage 2.32 2 0 0.0 0.00 1.0e+00 DENND1A LRRC37A4P
Hand grip strength (right) 2.81 3 1 2.2 0.00 1.0e+00 LRP1 LRRC37A4P RP1-257A7.5
Fed-up feelings 6.83 2 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123
Relative age voice broke 4.95 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Taking other prescription medications 3.00 1 0 0.0 0.00 1.0e+00 RNF123
Age when periods started (menarche) 2.79 2 1 2.2 0.00 1.0e+00 LRRC37A4P RNF123
Heel bone mineral density (BMD) T-score, automated (left) 1.56 1 0 0.0 0.00 1.0e+00 LRRC37A4P
High blood pressure 3.47 3 0 0.0 0.00 1.0e+00 LRRC37A4P PTK2 SDCCAG8
Hayfever, allergic rhinitis or eczema 1.55 1 0 0.0 0.00 1.0e+00 LRP1
Multivitamins +/- minerals 2.45 1 0 0.0 0.00 1.0e+00 LRP1
Sitting height 2.40 2 2 4.4 0.00 1.0e+00 LRP1 LRRC37A4P
Body mass index (BMI) 2.64 2 1 2.2 0.00 1.0e+00 DENND1A RNF123
Impedance of leg (left) 2.48 3 2 4.4 0.00 1.0e+00 LRRC37A4P PTK2 RNF123
Leg predicted mass (left) 1.31 1 0 0.0 0.00 1.0e+00 RNF123
Trunk fat mass 2.04 3 0 0.0 0.00 1.0e+00 DENND1A LRRC37A4P RNF123
Waist circumference 1.77 1 0 0.0 0.00 1.0e+00 DENND1A
Past tobacco smoking 2.79 1 0 0.0 0.00 1.0e+00 RNF123
Alcohol usually taken with meals 3.18 1 0 0.0 0.00 1.0e+00 RABGAP1L
Nervous feelings 4.01 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Frequency of tenseness / restlessness in last 2 weeks 6.55 2 1 2.2 0.00 1.0e+00 LRRC37A4P RNF123
Hearing difficulty/problems with background noise 3.14 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Hair/balding pattern: Pattern 2 3.35 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Forced vital capacity (FVC) 6.29 3 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123 U91328.21
Ever unenthusiastic/disinterested for a whole week 4.24 2 0 0.0 0.00 1.0e+00 LRRC37A4P RNF123
Qualifications: None of the above 4.69 2 1 2.2 0.00 1.0e+00 PTK2 RNF123
Mouth/teeth dental problems 4.26 2 0 0.0 0.00 1.0e+00 PTK2 SDCCAG8
Heart attack 5.79 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Allergy 2.04 1 0 0.0 0.00 1.0e+00 LRP1
Pain all over the body in last month 2.27 1 0 0.0 0.00 1.0e+00 RNF123
Hayfever/allergic rhinitis (self-reported) 2.78 1 0 0.0 0.00 1.0e+00 LRP1
Fluid intelligence score 4.22 2 0 0.0 0.00 1.0e+00 RNF123 U91328.21
Neuroticism score 7.20 2 1 2.2 0.00 1.0e+00 LRRC37A4P RABGAP1L
Weight 1.82 2 1 2.2 0.00 1.0e+00 DENND1A RNF123
Impedance of arm (right) 3.20 2 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123
Arm fat percentage (right) 1.80 2 0 0.0 0.00 1.0e+00 DENND1A RNF123
Trunk fat-free mass 1.47 2 1 2.2 0.00 1.0e+00 RABGAP1L RNF123
Hip circumference 1.79 1 0 0.0 0.00 1.0e+00 RNF123
Time employed in main current job 3.02 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Worrier / anxious feelings 2.53 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Frequency of tiredness / lethargy in last 2 weeks 4.08 1 0 0.0 0.00 1.0e+00 RNF123
Hair/balding pattern: Pattern 3 5.70 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Number of live births 2.06 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Forced expiratory volume in 1-second (FEV1) 7.50 3 3 6.7 0.00 1.0e+00 LRRC37A4P RNF123 U91328.21
Qualifications: A levels/AS levels or equivalent 4.90 3 1 2.2 0.00 1.0e+00 LRRC37A4P RNF123 SDCCAG8
Mouth/teeth dental problems: Dentures 3.19 1 0 0.0 0.00 1.0e+00 RNF123
Asthma 3.88 2 0 0.0 0.00 1.0e+00 LRP1 U91328.21
Medication: Ibuprofen (e.g. Nurofen) 13.86 5 2 4.4 0.98 3.0e-03 KIAA0776 LRP1 LRRC37A4P RP1-257A7.5 U91328.21
Forced expiratory volume in 1-second (FEV1), Best measure 6.97 3 3 6.7 0.00 1.0e+00 LRRC37A4P RNF123 U91328.21
Pulse wave Arterial Stiffness index 2.67 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Impedance of arm (left) 3.54 2 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123
Arm fat mass (right) 1.94 2 1 2.2 0.00 1.0e+00 DENND1A RNF123
Trunk predicted mass 1.44 4 1 2.2 -0.17 8.3e-01 LRP1 PTK2 RABGAP1L RNF123
Standing height 0.95 3 2 4.4 0.00 1.0e+00 LRP1 LRRC37A4P U91328.21
Exposure to tobacco smoke at home 2.45 1 0 0.0 0.00 1.0e+00 RNF123
Tense / 'highly strung' 3.68 1 1 2.2 0.00 1.0e+00 RABGAP1L
Seen doctor (GP) for nerves, anxiety, tension or depression 3.48 1 0 0.0 0.00 1.0e+00 U91328.21
Hair/balding pattern: Pattern 4 10.69 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Birth weight of first child 2.91 1 1 2.2 0.00 1.0e+00 PTK2
Peak expiratory flow (PEF) 4.43 2 1 2.2 0.00 1.0e+00 LRRC37A4P U91328.21
Ever highly irritable/argumentative for 2 days 2.56 1 0 0.0 0.00 1.0e+00 RNF123
Qualifications: O levels/GCSEs or equivalent 2.75 1 0 0.0 0.00 1.0e+00 RNF123
Headache pain in last month 28.96 7 6 13.3 0.95 1.1e-03 KIAA0776 LRP1 LRRC37A4P RABGAP1L RP1-257A7.5 SDCCAG8 U91328.21
Hypothyroidism/myxoedema (self-reported) 2.01 1 0 0.0 0.00 1.0e+00 PTK2
Birth weight 2.47 1 0 0.0 0.00 1.0e+00 PTK2
Forced vital capacity (FVC), Best measure 5.75 3 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123 U91328.21
Body fat percentage 2.37 2 0 0.0 0.00 1.0e+00 DENND1A LRP1
Leg fat percentage (right) 3.02 3 1 2.2 0.00 1.0e+00 DENND1A LRP1 RNF123
Arm fat-free mass (right) 1.52 1 1 2.2 0.00 1.0e+00 RNF123
Exposure to tobacco smoke outside home 4.70 2 0 0.0 0.00 1.0e+00 DENND1A SDCCAG8
Comparative body size at age 10 1.45 1 0 0.0 0.00 1.0e+00 U91328.21
Worry too long after embarrassment 2.77 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Wheeze or whistling in the chest in last year 3.76 1 0 0.0 0.00 1.0e+00 RNF123
Age at first live birth 3.86 1 1 2.2 0.00 1.0e+00 RNF123
Pulse wave peak to peak time 2.54 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Qualifications: College or University degree 7.75 5 4 8.9 -0.97 4.8e-03 LRRC37A4P PTK2 RABGAP1L RNF123 SDCCAG8
Medication for pain relief, constipation, heartburn 19.69 9 6 13.3 -0.99 4.9e-07 DENND1A KIAA0776 LRP1 LRRC37A4P PTK2 RABGAP1L RP1-257A7.5 SDCCAG8 U91328.21
Neck or shoulder pain in last month 4.23 1 0 0.0 0.00 1.0e+00 PTK2
Angina (self-reported) 2.90 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Migraine (self-reported) 18.49 3 3 6.7 0.00 1.0e+00 KIAA0776 LRP1 RP1-257A7.5
Medication: Ibuprofen 10.66 3 2 4.4 0.00 1.0e+00 LRP1 LRRC37A4P RP1-257A7.5
Heart disease (mother) 3.30 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Whole body fat mass 2.14 2 1 2.2 0.00 1.0e+00 DENND1A RNF123
Leg fat mass (right) 2.69 2 1 2.2 0.00 1.0e+00 DENND1A RNF123
Arm predicted mass (right) 1.67 1 1 2.2 0.00 1.0e+00 RNF123
Pulse rate, automated reading 2.13 2 0 0.0 0.00 1.0e+00 RNF123 RP1-257A7.5
Alcohol intake frequency. 4.49 3 1 2.2 0.00 1.0e+00 LRP1 LRRC37A4P RP1-257A7.5
Comparative height size at age 10 1.51 2 2 4.4 0.00 1.0e+00 LRRC37A4P U91328.21
Suffer from 'nerves' 2.57 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Overall health rating 5.27 2 2 4.4 0.00 1.0e+00 RNF123 SDCCAG8
Chest pain or discomfort 1.84 1 0 0.0 0.00 1.0e+00 RNF123
Age at last live birth 3.51 1 1 2.2 0.00 1.0e+00 RNF123
Knee pain experienced in last month 5.42 3 0 0.0 0.00 1.0e+00 PTK2 RABGAP1L SDCCAG8
Hypertension (Self-reported) 3.21 2 0 0.0 0.00 1.0e+00 PTK2 SDCCAG8
Illnesses of father: Heart disease 4.38 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Whole body fat-free mass 1.40 1 1 2.2 0.00 1.0e+00 RNF123
Leg fat-free mass (right) 1.24 1 0 0.0 0.00 1.0e+00 RNF123
Arm fat percentage (left) 1.84 2 0 0.0 0.00 1.0e+00 DENND1A RNF123
Handedness (chirality/laterality): Left-handed 3.37 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Mood swings 7.98 3 2 4.4 0.00 1.0e+00 LRRC37A4P PTK2 RNF123
Loneliness, isolation 3.08 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Mouth/teeth dental problems: Mouth ulcers 4.32 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Medication for cholesterol 1.95 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Back pain experienced in last month 3.97 1 0 0.0 0.00 1.0e+00 PTK2
Mineral and other dietary supplements 2.61 1 0 0.0 0.00 1.0e+00 LRP1
Asthma (self-reported) 3.71 2 0 0.0 0.00 1.0e+00 LRP1 U91328.21
Osteoarthritis (self-reported) 3.27 1 0 0.0 0.00 1.0e+00 PTK2
Forced expiratory volume in 1-second (FEV1), predicted percentage 7.42 3 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123 U91328.21
Whole body water mass 1.44 1 1 2.2 0.00 1.0e+00 RNF123
Leg predicted mass (right) 1.22 2 0 0.0 0.00 1.0e+00 PTK2 RNF123
Arm fat mass (left) 1.86 2 1 2.2 0.00 1.0e+00 DENND1A RNF123
Average weekly champagne plus white wine intake 3.74 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Miserableness 7.15 3 2 4.4 0.00 1.0e+00 LRRC37A4P RNF123 SDCCAG8
Guilty feelings 4.86 2 1 2.2 0.00 1.0e+00 LRRC37A4P RNF123
Financial situation satisfaction 2.90 1 0 0.0 0.00 1.0e+00 RNF123
Medication: Blood pressure 2.80 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Supplements: Fish oil (including cod liver oil) 2.94 1 0 0.0 0.00 1.0e+00 LRP1
Medication: Paracetamol 20.23 10 6 13.3 0.99 4.8e-09 DENND1A KIAA0776 LRP1 LRRC37A4P PTK2 RABGAP1L RNF123 RP1-257A7.5 SDCCAG8 U91328.21
Ever smoked 2.54 1 0 0.0 0.00 1.0e+00 RNF123
Basal metabolic rate 1.44 1 1 2.2 0.00 1.0e+00 RNF123
Leg fat percentage (left) 2.97 3 1 2.2 0.00 1.0e+00 DENND1A LRP1 RNF123
Arm fat-free mass (left) 1.63 1 1 2.2 0.00 1.0e+00 RNF123
Number of operations (self-reported) 4.11 1 0 0.0 0.00 1.0e+00 RNF123
Average weekly beer plus cider intake 3.22 1 0 0.0 0.00 1.0e+00 RNF123
Irritability 3.74 1 1 2.2 0.00 1.0e+00 LRRC37A4P
Risk taking 2.61 1 0 0.0 0.00 1.0e+00 SDCCAG8
Ever had prostate specific antigen (PSA) test 2.41 1 0 0.0 0.00 1.0e+00 U91328.21
Diastolic blood pressure, automated reading 5.23 2 2 4.4 0.00 1.0e+00 SDCCAG8 U91328.21
Ever depressed for a whole week 3.07 1 0 0.0 0.00 1.0e+00 RNF123
Myopia 4.15 1 0 0.0 0.00 1.0e+00 LRP1
Vascular/heart problems diagnosed by doctor 2.68 2 0 0.0 0.00 1.0e+00 PTK2 SDCCAG8
Pain experienced in last month 9.72 5 1 2.2 -0.99 1.2e-03 LRP1 LRRC37A4P PTK2 RABGAP1L RNF123
Heart attack/myocardial infarction (self-reported) 5.76 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Heart disease (siblings) 3.72 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Impedance of whole body 3.30 3 3 6.7 0.00 1.0e+00 LRRC37A4P PTK2 RNF123
Leg fat mass (left) 2.62 2 1 2.2 0.00 1.0e+00 DENND1A RNF123
Arm predicted mass (left) 1.67 2 1 2.2 0.00 1.0e+00 RABGAP1L RNF123

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 9 0.258 1.7
GTEx Adipose Visceral Omentum 6 0.295 1.8
GTEx Adrenal Gland 5 0.343 1.7
GTEx Artery Aorta 11 0.369 1.8
GTEx Artery Coronary 10 0.845 2.1
GTEx Artery Tibial 10 0.266 1.8
GTEx Brain Caudate basal ganglia 6 0.652 1.7
GTEx Brain Cerebellar Hemisphere 6 0.403 1.7
GTEx Brain Cerebellum 7 0.353 1.8
GTEx Brain Cortex 7 0.676 1.8
GTEx Brain Frontal Cortex BA9 6 0.649 1.8
GTEx Brain Hippocampus 4 0.763 1.9
GTEx Brain Hypothalamus 4 0.678 1.9
GTEx Brain Nucleus accumbens basal ganglia 6 0.694 1.9
GTEx Brain Putamen basal ganglia 5 0.801 2.0
GTEx Breast Mammary Tissue 9 0.456 1.8
GTEx Breast Mammary Tissue (Male) 7 0.587 1.8
GTEx Breast Mammary Tissue (Female) 8 0.487 1.8
GTEx Cells EBV-transformed lymphocytes 9 0.632 1.9
GTEx Cells Transformed fibroblasts 10 0.238 1.7
GTEx Colon Sigmoid 7 0.479 1.9
GTEx Colon Transverse 9 0.436 1.8
GTEx Esophagus Gastroesophageal Junction 8 0.554 1.9
GTEx Esophagus Mucosa 11 0.331 1.7
GTEx Esophagus Muscularis 11 0.340 1.8
GTEx Heart Atrial Appendage 8 0.507 1.7
GTEx Heart Left Ventricle 7 0.458 1.7
GTEx Liver 4 0.558 1.8
GTEx Lung 9 0.313 1.7
GTEx Muscle Skeletal 8 0.277 1.7
GTEx Nerve Tibial 9 0.208 1.7
GTEx Ovary 6 0.661 1.9
GTEx Pancreas 7 0.429 1.9
GTEx Pituitary 5 0.448 1.8
GTEx Prostate 5 0.599 1.9
GTEx Skin Not Sun Exposed Suprapubic 8 0.325 1.8
GTEx Skin Sun Exposed Lower leg 9 0.247 1.8
GTEx Small Intestine Terminal Ileum 4 0.868 2.0
GTEx Spleen 5 0.354 1.7
GTEx Stomach 7 0.481 1.8
GTEx Testis 10 0.317 1.8
GTEx Thyroid 10 0.250 1.7
GTEx Uterus 6 1.058 2.1
GTEx Vagina 5 0.787 2.0
GTEx Whole Blood 6 0.301 1.7
METSIM Adipose 2 0.043 1.5
NTR Blood 4 0.167 1.6
ROSMAP Brain Pre-frontal Cortex 0 0.000 1.6
YFS Blood 0 0.000 1.5
CommonMind Brain Pre-frontal Cortex 4 0.074 1.5
The Cancer Genome Atlas Bladder Urothelial Carcinoma 3 0.181 1.6
The Cancer Genome Atlas Breast Invasive Carcinoma 2 0.045 1.5
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 3 0.273 1.6
The Cancer Genome Atlas Colon Adenocarcinoma 1 0.048 1.4
The Cancer Genome Atlas Esophageal Carcinoma 3 0.438 1.7
The Cancer Genome Atlas Glioblastoma Multiforme 1 0.098 1.6
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 2 0.073 1.5
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 6 0.146 1.5
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 2 0.098 1.5
The Cancer Genome Atlas Brain Lower Grade Glioma 4 0.093 1.5
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 3 0.271 1.5
The Cancer Genome Atlas Lung Adenocarcinoma 5 0.170 1.6
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 4 0.160 1.6
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 4 0.251 1.5
The Cancer Genome Atlas Pancreatic Adenocarcinoma 4 0.241 1.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 4 0.301 1.6
The Cancer Genome Atlas Prostate Adenocarcinoma 8 0.173 1.5
The Cancer Genome Atlas Rectum Adenocarcinoma 3 0.434 1.6
The Cancer Genome Atlas Soft Tissue Sarcoma 4 0.375 1.6
The Cancer Genome Atlas Skin Cutaneous Melanoma 1 0.187 1.6
The Cancer Genome Atlas Stomach Adenocarcinoma 3 0.178 1.5
The Cancer Genome Atlas Testicular Germ Cell Tumors 1 0.078 1.5
The Cancer Genome Atlas Thyroid Carcinoma 4 0.078 1.5
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 2 0.394 1.6